Kobo Biotech - Quaterly Results

14 Aug 2024 Evaluate
Revenue reduced marginally to stand at Rs. 0.00 millions during the quarter ended June 2024. The figure stood at Rs. 0.00 millions during the year-ago period.The Net Loss for the quarter ended June 2024 is Rs. -13.29 millions as compared to Net Loss of Rs. -12.26 millions of corresponding quarter ended June 2023 Operating profit Margin for the quarter ended June 2024 further decreased to -3.18% as compared to -2.13% of corresponding quarter ended June 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.24 0.15 60.00 0.24 0.15 60.00 0.15 0.15 0.00
PBIDT -3.18 -2.13 49.30 -3.18 -2.13 49.30 -8.58 -14.81 -42.07
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -3.18 -2.13 49.30 -3.18 -2.13 49.30 -8.58 -14.81 -42.07
Depreciation 10.11 10.13 -0.20 10.11 10.13 -0.20 40.71 40.72 -0.02
PBT -13.29 -12.26 8.40 -13.29 -12.26 8.40 -49.29 -55.53 -11.24
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -13.29 -12.26 8.40 -13.29 -12.26 8.40 -49.29 -55.53 -11.24
Equity 238.25 238.25 0.00 238.25 238.25 0.00 238.25 238.25 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Kobo Biotech Share Price

3.15 0.15 (5.00%)
28-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1735.45
Dr. Reddys Lab 1144.05
Cipla 1441.70
Lupin 2026.50
Zydus Lifesciences 885.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...